1050 Single cell transcriptome and epigenome profiling reveals the diversity of T cell states inex vivogrown tumor-infiltrating lymphocytes from malignant pleural mesothelioma

K. Tomczak, Carlos Ramos, Nathaniel Deboever, N. Zhou, Jacqueline Liszeth Oliva, Changping Wu, C. Strange, A. Weissferdt, D. Rice, R. Mehran, Jianjun Zhang, M. Altan, A. Tsao, B. Sepesi, C. Haymaker
{"title":"1050 Single cell transcriptome and epigenome profiling reveals the diversity of T cell states inex vivogrown tumor-infiltrating lymphocytes from malignant pleural mesothelioma","authors":"K. Tomczak, Carlos Ramos, Nathaniel Deboever, N. Zhou, Jacqueline Liszeth Oliva, Changping Wu, C. Strange, A. Weissferdt, D. Rice, R. Mehran, Jianjun Zhang, M. Altan, A. Tsao, B. Sepesi, C. Haymaker","doi":"10.1136/jitc-2022-sitc2022.1050","DOIUrl":null,"url":null,"abstract":"Background Malignant pleural mesothelioma (MPM) is a rare and aggressive cancer associated with exposure to asbestos that lacks effective treatment options. 1 Immunotherapy approaches remain challenging with a current paucity of knowledge on the tumor-infiltrating lymphocyte (TIL) land-scape. 2 We aimed to generate a reference transcriptomic and epigenomic atlas of MPM T cell subpopulations that could inform on cellular features and states of propagated ex vivo cells to allow new immunotherapy design. IL9R-Tcells, five CD8-MKI67 and CD8-TOX), four gamma-delta T cell clusters (?d-TRDC), and one unique cluster (MALAT1). scATAC-seq analysis of the MPM TIL paired with their transcriptomic clusters validated the presence of existing cell states with trajectory analysis confirming the separation of the distinct cell states. Activation and inhibitory markers showed heterogenous pattern. Upregulation of activation markers OX40 ( TNFRSF4*** ) and ICOS*** was present in CD4-CD40LG and OX40 ( TNFRSF4*** ) marker in IL9R-Tcells. Moreover, CD4-CD40LG showed high upregulation of CTLA4*** and GITR ( TNFRSF18*** ), whereas, among CD8+ subsets, GITR *** expression was observed only in gd -TRDC and IL9R-Tcells. gd -TRDC also displayed heterogenous upregulation of other inhibitory markers LAG3 and TOX.","PeriodicalId":398566,"journal":{"name":"Regular and Young Investigator Award Abstracts","volume":"48 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Regular and Young Investigator Award Abstracts","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/jitc-2022-sitc2022.1050","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background Malignant pleural mesothelioma (MPM) is a rare and aggressive cancer associated with exposure to asbestos that lacks effective treatment options. 1 Immunotherapy approaches remain challenging with a current paucity of knowledge on the tumor-infiltrating lymphocyte (TIL) land-scape. 2 We aimed to generate a reference transcriptomic and epigenomic atlas of MPM T cell subpopulations that could inform on cellular features and states of propagated ex vivo cells to allow new immunotherapy design. IL9R-Tcells, five CD8-MKI67 and CD8-TOX), four gamma-delta T cell clusters (?d-TRDC), and one unique cluster (MALAT1). scATAC-seq analysis of the MPM TIL paired with their transcriptomic clusters validated the presence of existing cell states with trajectory analysis confirming the separation of the distinct cell states. Activation and inhibitory markers showed heterogenous pattern. Upregulation of activation markers OX40 ( TNFRSF4*** ) and ICOS*** was present in CD4-CD40LG and OX40 ( TNFRSF4*** ) marker in IL9R-Tcells. Moreover, CD4-CD40LG showed high upregulation of CTLA4*** and GITR ( TNFRSF18*** ), whereas, among CD8+ subsets, GITR *** expression was observed only in gd -TRDC and IL9R-Tcells. gd -TRDC also displayed heterogenous upregulation of other inhibitory markers LAG3 and TOX.
1050单细胞转录组和表观基因组分析揭示了恶性胸膜间皮瘤肿瘤浸润淋巴细胞体内T细胞状态的多样性
恶性胸膜间皮瘤(MPM)是一种罕见的侵袭性癌症,与暴露于石棉有关,缺乏有效的治疗方案。由于目前对肿瘤浸润性淋巴细胞(TIL)领域的知识缺乏,免疫治疗方法仍然具有挑战性。我们的目标是生成MPM T细胞亚群的参考转录组学和表观基因组图谱,该图谱可以告知细胞特征和体外繁殖细胞的状态,从而允许新的免疫治疗设计。il9r -T细胞,5个CD8-MKI67和CD8-TOX), 4个γ - δ T细胞簇(d-TRDC)和1个独特的簇(MALAT1)。对MPM TIL与其转录组簇配对的scATAC-seq分析验证了现有细胞状态的存在,轨迹分析证实了不同细胞状态的分离。激活和抑制标记呈异质模式。il - 9r - t细胞CD4-CD40LG和OX40 (TNFRSF4***)标志物激活标志物OX40 (TNFRSF4***)和ICOS***上调。此外,CD4-CD40LG高表达CTLA4***和GITR (TNFRSF18***),而在CD8+亚群中,GITR ***仅在gd -TRDC和il9r - t细胞中表达。gd -TRDC对其他抑制标志物LAG3和TOX也表现出异质性上调。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信